Acadian Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Acadian Asset Management's LMAT Position: Q1 2026 in Review
Acadian Asset Management reduced its LeMaitre Vascular (LMAT) stake by 73% in Q1 2026, selling an estimated $1.08M and leaving 4,232 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.
Acadian Asset Management first reported a position in LMAT in Q3 2015 and has held it in 24 quarters since. The position peaked at $2.86M in Q1 2016. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Acadian Asset Management held 4,232 shares of LeMaitre Vascular worth $461K as of Q1 2026.
- Acadian Asset Management sold 11,282 LeMaitre Vascular shares in Q1 2026, an estimated $1.08M.
- LeMaitre Vascular made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1378 holding.
- Acadian Asset Management first reported a position in LeMaitre Vascular in Q3 2015 and has held it in 24 quarters since.
- Acadian Asset Management's LeMaitre Vascular position peaked at $2.86M in Q1 2016.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.